By Chioma Obinna PFIZER Incorporation and BioNTech have dosed first participants in the United State, US, in the Phase  1/2 clinical trial for the BNT162 vaccine programme to prevent COVID-19. The trial is part of a global development programme and the dosing of the first cohort in Germany was completed last week. The Phase […]